carbon monoxide has been researched along with Xerostomia in 1 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Xerostomia: Decreased salivary flow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The primary aim of this study was to determine the safety and efficacy of the monoamine oxidase-B (MAO-B) inhibitor selegiline hydrochloride (SEL, l-Deprenyl; Eldepryl) as an aid for smoking cessation in cigarette smokers." | 9.14 | A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers. ( George, TP; Jatlow, PI; O'Malley, SS; Potenza, MN; Reutenauer, EL; Weinberger, AH, 2010) |
| "The primary aim of this study was to determine the safety and efficacy of the monoamine oxidase-B (MAO-B) inhibitor selegiline hydrochloride (SEL, l-Deprenyl; Eldepryl) as an aid for smoking cessation in cigarette smokers." | 5.14 | A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers. ( George, TP; Jatlow, PI; O'Malley, SS; Potenza, MN; Reutenauer, EL; Weinberger, AH, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weinberger, AH | 1 |
| Reutenauer, EL | 1 |
| Jatlow, PI | 1 |
| O'Malley, SS | 1 |
| Potenza, MN | 1 |
| George, TP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Usefulness of Selegiline for Smoking Cessation[NCT00129311] | Phase 2 | 101 participants (Actual) | Interventional | 2004-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00129311)
Timeframe: 6-month follow up
| Intervention | participants (Number) |
|---|---|
| Selegiline | 6 |
| Placebo | 8 |
(NCT00129311)
Timeframe: Week 8
| Intervention | participants (Number) |
|---|---|
| Selegiline | 8 |
| Placebo | 10 |
1 trial available for carbon monoxide and Xerostomia
| Article | Year |
|---|---|
A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.
Topics: Administration, Oral; Adolescent; Adult; Aged; Carbon Monoxide; Cotinine; Dizziness; Double-Blind Me | 2010 |